NCT06577987 Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies Status RECRUITING Phase PHASE1
NCT06540937 Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor Status RECRUITING Phase PHASE2
NCT06505824 A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors Status RECRUITING Phase PHASE1
NCT06485739 Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma Status NOT_YET_RECRUITING Phase PHASE4
NCT06472388 Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors Status RECRUITING Phase PHASE2
NCT06456723 Evaluation of [18F]Fluoroethyl Triazole Labelled [Tyr3]-Octreotate Analogues for the Imaging of Neuroendocrine Tumours. Status COMPLETED Phase PHASE1/PHASE2
NCT06455358 61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET) Status RECRUITING Phase PHASE1/PHASE2
NCT06448208 Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06430021 Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation Status RECRUITING Phase N/A
NCT06395402 177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry Status RECRUITING Phase PHASE2
NCT06356467 Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs Status RECRUITING Phase N/A
NCT06345079 Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours Status RECRUITING Phase PHASE2
NCT06344507 Iconographic Registry of Pancreatobiliary Endoscopy Procedures Status RECRUITING Phase N/A
NCT06321692 Early Identification of Cardiac Involvement in Patients With Carcinoid: Clinical and Prognostic Implications Status RECRUITING Phase NA
NCT06300216 A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors Status NOT_YET_RECRUITING Phase N/A
NCT06263088 EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. Status RECRUITING Phase NA